Compounds comprising lpa
Номер патента: EP1660539A2
Опубликовано: 31-05-2006
Автор(ы): Arne Holm, Elisabeth Bock, Morten Albrechtsen, Vladimir Berezin
Принадлежит: Enkam Pharmaceuticals AS
Опубликовано: 31-05-2006
Автор(ы): Arne Holm, Elisabeth Bock, Morten Albrechtsen, Vladimir Berezin
Принадлежит: Enkam Pharmaceuticals AS
Реферат: The present invention relates to new peptide compounds capable of binding to fibroblast growth factor receptor (FGFR), said compounds comprising two individual amino acid sequences, wherein at least one of the two amino acid sequences is capable of binding to FGFR. The invention discloses the amino acid sequences of the compounds and features pharmaceutical compositions comprising thereof. Invention also relates to uses of the compounds and pharmaceutical compositions comprising thereof for the treatment or prevention of different pathological conditions, wherein FGFR plays a role in pathology and/or recovery from the disease. New peptide compounds of the invention are obtainable by the ligand presenting assembly (LPA) method.
Compounds comprising lpa
Номер патента: IL173532A0. Автор: . Владелец: Enkam Pharmaceuticals AS. Дата публикации: 2006-07-05.